A Breakthrough in Treating PTSD: MDMA Assisted Psychotherapy

💡Approximately half of all individuals will experience at least one significant trauma in their lifetime.

🩺PTSD is a serious psychiatric condition that can have debilitating effects on an individual's daily life.

📈Current treatments for PTSD, such as antidepressants and psychotherapy, may not provide long-lasting relief for many individuals.

✨MDMA Assisted Psychotherapy has shown promising results in clinical trials, with up to 68% of participants no longer meeting the diagnostic criteria for PTSD after just three sessions.

🌍The Multidisciplinary Association for Psychedelic Studies (MAPS) is leading the research and development of MDMA Assisted Psychotherapy, with the aim of obtaining FDA approval and providing effective treatment for PTSD.

What is MDMA Assisted Psychotherapy?

—MDMA Assisted Psychotherapy is a treatment that combines the use of MDMA, a drug that has shown therapeutic effects, with traditional psychotherapy. It aims to enhance the effectiveness of therapy for individuals suffering from PTSD.

How does MDMA Assisted Psychotherapy work?

—MDMA works on the serotonin system and prompts the release of dopamine and hormones associated with trust and bonding. In combination with psychotherapy, it can improve mood, memory, focus, motivation, and reduce the fight-or-flight response.

What are the results of clinical trials?

—Phase 2 trials showed that after just three sessions of MDMA Assisted Psychotherapy, up to 68% of participants no longer met the diagnostic criteria for PTSD. Long-term follow-up showed sustained improvement in symptoms.

Are there any side effects or risks?

—MDMA Assisted Psychotherapy is conducted under therapeutic supervision and involves thorough safety screenings. While there are temporary side effects during the drug's effects, there is no evidence of dependence or abuse. People with certain medical conditions may not be suitable for this treatment.

When will MDMA Assisted Psychotherapy be available?

—If phase 3 trials are successful and replicate the previous results, FDA approval for MDMA Assisted Psychotherapy is expected as early as 2021.

00:00Approximately half of all individuals will experience at least one significant trauma in their lifetime.

04:58MDMA Assisted Psychotherapy, a treatment that combines the use of MDMA and traditional psychotherapy, has shown promising results in reducing PTSD symptoms.

09:12Phase 2 clinical trials demonstrated that after just three sessions of MDMA Assisted Psychotherapy, up to 68% of participants no longer met the diagnostic criteria for PTSD.

13:56The Multidisciplinary Association for Psychedelic Studies (MAPS) is leading the research and development of MDMA Assisted Psychotherapy, with the aim of obtaining FDA approval.